In Vitro Activities of Ertapenem (MK-0826) against Clinical Bacterial Isolates from 11 North American Medical Centers

This study compared the in vitro activities of the new long-half-life carbapenem ertapenem (also known as MK-0826 and L-749,345) with those of imipenem, amoxicillin-clavulanate, and ciprofloxacin against 5,558 recent clinical isolates from 11 North American medical centers. We confirmed the greater...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Fuchs, Peter C., Barry, Arthur L., Brown, Steven D.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2001
Materias:
Susceptibility
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC90573/
https://ncbi.nlm.nih.gov/pubmed/11353653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.45.6.1915-1918.2001
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares